Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Combined Guanfacine and Mindfulness Meditation as an Adjunct to Buprenorphine Maintenance in Opioid Use Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating whether adding guanfacine and mindfulness meditation to buprenorphine maintenance is feasible and tolerable in opioid use diso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guanfacine (guanfacine)
  • buprenorphine (buprenorphine)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Mindfulness, Guanfacine | Phase 1 | Status: RECRUITING